Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant <i>Klebsiella Pneumoniae</i>: Exploring A Colistin Sparing Protocol

• Main Authors: Manawr AL-Quraini (Author), Meher Rizvi (Author), Zaaima AL-Jabri (Author), Hiba Sami (Author), Muna AL-Muzahmi (Author), Zakariya AL-Muharrmi (Author), Neelam Taneja (Author), Ibrahim AL-Busaidi (Author), Rajeev Soman (Author)
• Format: Book
• Published: MDPI AG, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Fosfomycin has emerged as a very useful antimicrobial in management of extremely drug resistant (XDR) and pan drug resistant (PDR) <i>Klebsiella pneumoniae</i>. In this study, we assessed in-vitro synergy of colistin sparing combinations of fosfomycin (FOS) with meropenem (MEM), tigecycl...